tradingkey.logo
搜尋

Fortrea Holdings Inc

FTRE
添加自選
17.880USD
+0.300+1.71%
交易中 美東報價延遲15分鐘
1.69B總市值
虧損本益比TTM

Fortrea Holdings Inc

17.880
+0.300+1.71%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.49%

5天

+4.83%

1月

+13.21%

6月

+3.43%

今年開始到現在

+3.43%

1年

+242.45%

關鍵數據
17.720今開
17.930最高
52.85K成交量
虧損本益比TTM
16.91本益比動
--股利TTM
0.06%換手率
17.580昨收
17.600最低
755.54K成交額
虧損本益比靜
3.22市淨率
0.00%股息率 TTM
-15.40%ROA
18.67052週最高
0.23量比
-328.50M淨利潤
94.60M總股本
-4.8182每股盈餘TTM
--Beta
-64.55%ROE
3.97052週最低
1.88%振幅
16.31%毛利率
1.69B總市值
3.02回報/風險
4.78%風險率

TradingKey Fortrea Holdings Inc股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Fortrea Holdings Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名39/387位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為16.85。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Fortrea Holdings Inc評分

相關信息

行業排名
39 / 387
全市場排名
119 / 4564
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看好

Fortrea Holdings Inc亮點

亮點風險
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入2.72B美元
估值合理
公司最新PE估值-3.65,處於3年歷史合理位
機構減倉
最新機構持股98.32M股,環比減少20.39%
巴羅·漢利持倉
明星投資者巴羅·漢利持倉,最新持倉68.09股

分析師目標

基於 11 分析師
買入
評級
16.850
目標均價
-3.16%
漲幅空間

Fortrea Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Fortrea Holdings Inc簡介

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
公司代碼FTRE
公司Fortrea Holdings Inc
CEOThakrala (Anshul)
網址https://www.fortrea.com/

常見問題

Fortrea Holdings Inc(FTRE)的當前股價是多少?

Fortrea Holdings Inc(FTRE)的當前股價是 17.58。

Fortrea Holdings Inc 的股票代碼是什麼?

Fortrea Holdings Inc的股票代碼是FTRE。

Fortrea Holdings Inc股票的52週最高點是多少?

Fortrea Holdings Inc股票的52週最高點是18.67。

Fortrea Holdings Inc股票的52週最低點是多少?

Fortrea Holdings Inc股票的52週最低點是3.97。

Fortrea Holdings Inc的市值是多少?

Fortrea Holdings Inc的市值是1.66B。

現在Fortrea Holdings Inc(FTRE)的股票是買入、持有還是賣出?

根據分析師評級,Fortrea Holdings Inc(FTRE)的總體評級為買入,目標價格為16.85。

Fortrea Holdings Inc(FTRE)股票的每股收益(EPS TTM)是多少

Fortrea Holdings Inc(FTRE)股票的每股收益(EPS TTM)是-10.81。